Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT00171392
Eligibility Criteria:
Inclusion Criteria:
* First or second (single or double) deceased or living donor kidney/kidney-pancreas transplant received at least six months previously;
* Immunosuppressive therapy with tacrolimus and mycophenolate mofetil (MMF);
Exclusion Criteria:
Subjects expected to discontinue tacrolimus therapy;
* Patients with thrombocytopenia (\<75,000/mm3), an absolute neutrophil count of \<1,500/mm3 and/or leukopenia (\<2,500/mm3), or anemia (hemoglobin \<6 g/dl) at baseline;
* Patients experiencing an acute rejection in the previous two months, with inadequate (creatininemia \>2.5 mg/dL) or worsening renal function in the previous two months.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00171392
Study Brief:
Protocol Section:
NCT00171392